Ikon aset - trading kripto, saham, dan emas di Pluang
Trading di Pluang
Satu platform untuk semua pasar
Download
Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Perbedaan Harga & Kinerja Archi Indonesia Tbk (ARCI) vs UBC Medical Indonesia Tbk. (LABS)

Archi Indonesia Tbk
UBC Medical Indonesia Tbk.

Kinerja harga

Pergerakan harga dalam 24 jam terakhir

Statistik utama

Perbedaan Archi Indonesia Tbk dan UBC Medical Indonesia Tbk.: Archi Indonesia Tbk diperdagangkan di Rp930 (kapitalisasi pasar 24,86 T, volume 24 jam 21,8 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp152 (kapitalisasi pasar 556,95 M, volume 24 jam 60,83 jt). Perbedaan utamanya: Archi Indonesia Tbk jauh lebih besar — sekitar 44,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (60,83 jt vs 21,8 jt). Mana yang lebih baik tergantung tujuan investasimu.

ARCILABS
Kapitalisasi Pasar
24,86 T556,95 M
Volume
21,8 jt60,83 jt
Lot
218,04 rb608,34 rb
Perputaran
20,81 M10,26 M
Harga Rata-rata
954,51168,64
Nilai Transaksi
20,81 M10,26 M
Harga Ekuilibrium Indikatif
930152
Volume Ekuilibrium Indikatif
5,48 rb4,52 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ARCI
Lihat detail
LABS
Lihat detail

Tentang Archi Indonesia Tbk

PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.

Selengkapnya di halaman ARCI

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS